# Artiva Biotherapeutics, Inc.: Form DEF 14A, filed Aug 3, 2026

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: DEF 14A
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 16:08 ET
- Period: 2026-09-08
- Accession: 0001193125-26-330563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000119312526330563/artv-20260803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000119312526330563/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000119312526330563/artv-20260803.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-330563. Last ingested by Listed: Nov 10, 2026, 01:58 ET. No prices; not investment advice.
